Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 01/22 03:04:48 pm
141.125 EUR   -0.09%
11:35aMERCK KGAA : Independant Research sticks Neutral
MD
07:12aMERCK KGAA : Barclays reaffirms its Neutral rating
MD
01/21MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck : Partners With Siemens on New Plant

11/26/2020 | 03:43am EST

By Olivia Bugault

Merck KGaA said Thursday that it will invest 10 million euros ($11.9 million) in a new plant as part of a partnership with German conglomerate Siemens AG to digitalize production.

The modular plant is expected to be completed by 2022 at Merck's site located in the Darmstadt region of Germany, it said.

The collaboration between Siemens and Merck will "result in the development of a process control system for the modular production of innovative materials and products for the electronics, pharmaceutical and life science industries," the German pharmaceuticals and chemicals company said.

The project is part of a broader program for Merck's global headquarters in Darmstadt, which totals EUR1 billion in investment to 2025, Merck said.

Write to Olivia Bugault at olivia.bugault@wsj.com

(END) Dow Jones Newswires

11-26-20 0343ET

Stocks mentioned in the article
ChangeLast1st jan.
MERCK KGAA -0.11% 141.1 Delayed Quote.0.64%
SIEMENS AG 7.27% 132.8 Delayed Quote.5.34%
All news about MERCK KGAA
11:35aMERCK KGAA : Independant Research sticks Neutral
MD
07:12aMERCK KGAA : Barclays reaffirms its Neutral rating
MD
01/21MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
01/21MERCK KGAA : Bernstein remains Neutral
MD
01/21MERCK KGAA : JP Morgan maintains a Buy rating
MD
01/21MERCK KGAA : UBS reaffirms its Neutral rating
MD
01/21MERCK : Discontinues Phase III Clinical Trial For Lung Cancer Drug On Failure To..
MT
01/20MERCK KGAA : Credit Suisse gives a Buy rating
MD
01/20MERCK KGAA : Sell rating from Goldman Sachs
MD
01/20MERCK : Shares Fall After Announcement of Cancer-Drug Trial Interruption
DJ
More news
Financials
Sales 2020 17 362 M 21 125 M 21 125 M
Net income 2020 1 977 M 2 405 M 2 405 M
Net Debt 2020 11 147 M 13 562 M 13 562 M
P/E ratio 2020 31,0x
Yield 2020 0,99%
Capitalization 61 347 M 74 677 M 74 642 M
EV / Sales 2020 4,18x
EV / Sales 2021 3,88x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 139,28 €
Last Close Price 141,25 €
Spread / Highest target 19,6%
Spread / Average Target -1,40%
Spread / Lowest Target -28,5%
EPS Revisions
Managers and Directors
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA0.64%74 584
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD11.98%27 823
KYOWA KIRIN CO., LTD.-1.28%14 661
BETTA PHARMACEUTICALS CO., LTD.33.28%8 595
YUHAN CORPORATION-3.60%4 335
RECIPHARM AB (PUBL)3.92%2 773